Asthma Drug, Salmeterol, Associated With Adverse Events In African Americans

... New data reveal that the asthma drug salmeterol may lead to an increased risk of respiratory - and asthma-related deaths in African American patients. In the Salmeterol Multicenter Asthma Research Trial (SMART), researchers from GlaxoSmithKline, Research Triangle Park, NC, National Jewish Medical and Research Center, Denver, CO, Brigham and Women''s Hospital, Boston, MA, and Wake Forest University School of Medicine, Winston Salem, NC, compared respiratory-related and asthma-related outcomes in 26,355 subjects (71 percent Caucasian and 18 percent African American) receiving usual asthma pharmacotherapy alone or usual asthma pharmacotherapy plus salmeterol for a duration of 28 weeks... click link for more info. ...